The effect of thoracoscopic and laparoscopic esophagectomy combined with TP chemotherapy on serum tumor-related factors and survivin protein expression of esophageal cancer patients
LIANG Min FU Maoyong WANG Lie LIANG Weiwei ZHANG Xiaoyan
Department of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Sichuan Province, Nanchong 637000, China
Abstract：Objective To explore the effect of thoracoscopic and laparoscopic esophagectomy combined with TP chemotherapy on serum tumor-related factors and survivin protein expression of esophageal cancer patients. Methods 100 cases of esophageal cancer patients treated in Affiliated Hospital of North Sichuan Medical College from August 2010 to August 2013 were selected. All patients were divided into control group and observation group according to the random number table method, thoracoscopic and laparoscopic esophagectomy was used in control group (50 cases), TP chemotherapy before surgery on the basis of control group was applied in observation group (50 cases). The surgery time, intraoperative bleeding, postoperative activity time, incidence rate of complication and prognosis between two groups were observed. Serum tumor markers [soluble major histo-compatibility complex class Ⅰ chain-related protain A (sMICA), transcription factor YY1 (YY1), cytokeratin 19 fragment antigen21-1 (Cyfra21-1)], malignant biological markers of serum tumors [matrix metalloprotein-9 (MMP-9), CD44v, vascular endothelial growth factor (VEGF)] and serum survivin protein of two groups were compared. Results The sMICA, YY1, Cyfra21-1, MMP-9, CD44v, VEGF, survivin protein of two groups after treatment were lower than before treatment (P < 0.05). The sMICA, YY1, Cyfra21-1, MMP-9, CD44v, VEGF, survivin protein of observation group after treatment were lower than those of control group (P < 0.05). The intraoperative bleeding of observation group was less than that of control group (P < 0.05). The postoperative activity time of observation group was shorter than that of control group (P < 0.05). There was no significant difference in operation time between two groups (P > 0.05). The incidence rate of postoperative complication in control group was significantly higher than that in observation group (P < 0.05). 3-year survival rate of control group was significantly lower than that of observation group (P < 0.05). Conclusion Thoracoscopic and laparoscopic esophagectomy combined with TP chemotherapy can significantly decrease the levels of serum tumor-related factors and serum survivin protein expression. Efficacy is significant, the incidence rate of complication is low. It is worthy of clinical promotion.
梁敏 付茂勇 王烈 梁维维 张小燕. 全腔镜食管癌根治术联合TP化疗方案对食管癌患者血清肿瘤相关因子及survivin蛋白表达的影响[J]. 中国医药导报, 2017, 14(23): 75-79.
LIANG Min FU Maoyong WANG Lie LIANG Weiwei ZHANG Xiaoyan. The effect of thoracoscopic and laparoscopic esophagectomy combined with TP chemotherapy on serum tumor-related factors and survivin protein expression of esophageal cancer patients. 中国医药导报, 2017, 14(23): 75-79.
[1] Lin Y，Totsuka Y，Shan B，et al. Esophageal cancer in high-risk areas of China：research progress and challenges [J]. Ann Epidemiol，2017，27（3）：215-221.
[2] 曾新敏，王晖，章志龙，等.胸腹腔镜微创手术与传统开胸手术对食管癌患者术后肺功能、炎症因子水平的影响[J].中国当代医药，2016，23（29）：79-81，110.
[3] 易军.紫杉醇、奈达铂化疗序贯放疗用于晚期食管癌的临床效果观察[J].中国当代医药，2016，23（23）：72-74.
[4] 卢帅.不同术式治疗早期胸段食管癌的临床疗效及对预后的影响[J].中国当代医药，2016，23（20）：63-65.
[5] Huang FL，Yu SJ. Esophageal cancer：risk factors，genetic association，and treatment [J]. Asian J Surg，2016，pii：S1015-9584(16)30201-9.
[6] Paireder M，Asari R，Kristo I，et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer [J]. Eur J Surg Oncol，2017，43（2）：478-484.
[7] Qiao Z，Dang C，Zhou B，et al. Downregulation of O-linked N-acetylglucosamine transferase by RNA interference decreases MMP9 expression in human esophageal cancer cells [J]. Oncol Lett，2016，11（5）：3317-3323.
[8] Terashima J，Sampei S，Iidzuka M，et al. VEGF expression is regulated by HIF-1α and ARNT in 3D KYSE-70，esophageal cancer cell spheroids [J]. Cell Biol Int，2016， 40（11）：1187-1194.
[9] Qin S，Xu C，Li S，et al. Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer [J]. Oncol Rep，2015，34（5）：2656-2664.
[10] Yang C，Wang H，Zhang B，et al. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC [J]. J Exp Clin Cancer Res，2016，35（1）：158-159.
[11] Short MW，Burgers KG，Fry VT. Esophageal cancer [J]. Am Fam Physician，2017，95（1）：22-28.
[12] 马建梅，陈承，潘谨，等.Survivin蛋白在食管鳞癌和肺鳞癌的表达异同探讨[J].蚌埠医学院学报，2015，40（1）：26-29.
[13] 冷长森，李印，刘先本，等.新辅助化疗联合胸腹腔镜手术治疗食管癌[J].中华胸心血管外科杂志，2015，31（9）：519-522.
[14] 刘永萱，冯笑山.食管癌根治性同步放化疗[J].国际肿瘤学杂志，2016，43（1）：49-52.
[15] 海平，赵仁，杨志花，等.局部晚期食管癌IMRT联合TP方案同步化疗疗效及毒副作用分析[J].中华肿瘤防治杂志，2015，22（b11）：90-91.
[16] Paireder M，Asari R，Kristo I，et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer [J]. Eur J Surg Oncol，2017，43（2）：478-484.
[17] 王庭丰，吕进，周国志.卡铂、紫杉醇新辅助化疗对食管癌患者心脏功能的影响[J].山东医药，2016，56（6）：7-9.
[18] 琳，吴兴平，丁伟龙，等.Cyfra21-1和CEA及CRP联合检测对食管癌诊断价值的探讨[J].中华肿瘤防治杂志，2012，19（9）：667-670.
[19] 李斌，李劲松，袁宁，等.78例食管癌患者CK20mRNA、CD44v6、NF-IcB表达的临床意义[J].重庆医学，2011， 40（20）：1995-1996.
[20] Xia H，Shen J，Chen S，et al. Overexpression of VEGF-C correlates with a poor prognosis in esophageal cancer patients [J]. Cancer Biomark，2016，17（2）：165-170.
[21] Luo J，Zhou X，Ge X，et al. Upregulation of Ying Yang 1 （YY1） suppresses esophageal squamous cell carcinoma development through heme oxygenase-1 [J]. Cancer Sci，2013，104（11）：1544-1551.
[22] Hu JM，Liu K，Liu JH，et al. The increased number of tumor-associated macrophage is associated with overexpression of VEGF-C，plays an important role in Kazakh ESCC invasion and metastasis [J]. Exp Mol Pathol，2017， 102（1）：15-21.
[23] Xia H，Chen S，Huang H，et al. Survivin over-expression is correlated with a poor prognosis in esophageal cancer patients [J]. Clin Chim Acta，2015，15（446）：82-85.
[24] Findlay JM，Bradley KM，Wang LM，et al. Predicting pathologic response of esophageal cancer to neoadjuvant chemotherapy：the implications of metabolic nodal response for personalized therapy [J]. J Nucl Med，2017，58（2）：266-275.
[25] 牛朝霞.Survivin与食管癌早期诊断治疗及预后的关系[J].新乡医学院学报，2016，33（3）：246-248.
2017, Vol. 14 
京公网安备 11010502046598号